Review
Open access
Sep 2026
Indications for Biological Treatment Combined with Allergen-Specific Immunotherapy: Who Is It Really Intended for?
The use of omalizumab, in combination with AIT, has proven to be an effective option in treating patients with allergic asthma and during food desensitization, particularly in the dose escalation phase when adverse reactions are more common.
M. Turkalj, I. Banić
· Journal of Clinical Medicine · 0 citations